MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients.
Zhang C, Liu H, Tan Y, Xu Y, Li Y, Tong S, Qiu S, Chen Q, Su Z, Tian D, Zhou W, Zhong C.
Zhang C, et al. Among authors: li y.
Front Immunol. 2022 Aug 9;13:865020. doi: 10.3389/fimmu.2022.865020. eCollection 2022.
Front Immunol. 2022.
PMID: 36119086
Free PMC article.